Details

Last Funding Type

Grant

Last Funding Money Raised

$2.30M

Industries

Biotechnology,Health Care,Medical

Founded date

Jan 1, 2011

Number Of Employee

11 - 50

Operating Status

Close

Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. The company identifies and selects lead vaccine candidates through its proprietary affinity optimizes those by in vitro and in vivo testing and develops them through pre-clinical and/or clinical testing until proof of concept is achieved establishing attractive out-licensing opportunities to Pharma or Biotech partners. Collaborations and partnerships are actively pursued within the industry, academia, and the government sector through NIAID.